Who we are
We care about rare disease patients
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
- Key therapeutic areas are Inflammation and Genetics & Metabolism.
- Our late stage pipeline includes three phase III programs with substantial potential.
- We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.
The Sobi head office is in Stockholm, Sweden. We are an organisation covering about 20 pan-European countries and the US.
Sobi UK covers the following countries: United Kingdom and Republic of Ireland.